Senator Investment Group’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,500,000
Closed -$65.2M 63
2022
Q1
$65.2M Hold
2,500,000
2.02% 18
2021
Q4
$71M Sell
2,500,000
-700,000
-22% -$21.8M 1.37% 25
2021
Q3
$102M Buy
3,200,000
+600,000
+23% +$20.1M 1.75% 11
2021
Q2
$90.2M Hold
2,600,000
1.71% 19
2021
Q1
$76.6M Hold
2,600,000
1.57% 21
2020
Q4
$79.7M Buy
2,600,000
+1,450,000
+126% +$44.2M 1.51% 19
2020
Q3
$32.1M Buy
+1,150,000
New +$29.1M 0.94% 38

Other funds holding ELAN

Senator Investment Group's ELAN Position: Q2 2022 in Review

Senator Investment Group sold out of Elanco Animal Health (ELAN) in Q2 2022, closing a stake of 2,500,000 shares — an estimated $65.2M sold.

Senator Investment Group first reported a position in ELAN in Q3 2020 and held it in 7 quarters. The position peaked at $102M in Q3 2021. 438 funds tracked by Wall St. Rank hold ELAN as of Q2 2022.

  • Senator Investment Group reported no remaining Elanco Animal Health position as of Q2 2022 after selling out during the quarter.
  • Senator Investment Group sold 2,500,000 Elanco Animal Health shares in Q2 2022, an estimated $65.2M.
  • Senator Investment Group first reported a position in Elanco Animal Health in Q3 2020 and held it in 7 quarters.
  • Senator Investment Group's Elanco Animal Health position peaked at $102M in Q3 2021.
  • 438 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2022.

Based on Senator Investment Group's 13F filing for Q2 2022, filed 15 Aug 2022.